Solutions for natural killer (NK) cell culture feature PRIME-XV® chemically-defined, animal component-free media to fulfill the potential of NK cell applications from basic and translational research to the clinic. Designed to deliver an optimal environment for ex vivo expansion, PRIME-XV NK cell media have been formulated to provide vigorous cell growth while maintaining NK cell functionality and potency—without the need for serum supplementation.
The PRIME-XV portfolio of products is specially designed to simplify the transition to clinical production while adhering to global and regional regulatory standards. Irvine Scientific understands that adherence to a stringent Quality Management System, including a robust Raw Material Program, is critical to ensuring traceability, consistency, and reliable performance in supporting immunotherapy applications.
To facilitate clinical applications and scale-up, PRIME-XV NK Cell CDM is available for custom formulation and packaging.